Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kezar Life Sciences Inc
(NQ:
KZR
)
0.6287
+0.0174 (+2.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Kezar Life Sciences Inc
< Previous
1
2
3
Next >
Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
August 13, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
July 10, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
June 07, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
May 29, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 06, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
April 08, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
March 14, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
March 08, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
February 28, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
February 26, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
November 13, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
November 03, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
October 23, 2023
Via
ACCESSWIRE
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
October 09, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer
October 03, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia
September 20, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Participate in Three Upcoming Investor Conferences
August 31, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 04, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
July 07, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 09, 2023
From
Kezar Life Sciences
Via
Business Wire
Kezar Life Sciences to Participate in the Jefferies Healthcare Conference
May 31, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 05, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update
March 14, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Change Virtual R&D Day Date to March 15, 2023
March 13, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Host Virtual R&D Day on March 22, 2023
March 06, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
March 03, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference
March 01, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.